@EmmaVP5

Physiologist and hypertension specialist @APHP, Bichat hospital, Paris, France @univ_paris_cite

Joined June 2019
  • Tweets153
  • Following226
  • Followers215
6Media
Emmanuelle Vidal-Petiot retweeted
Ph.Gabriel Steg@gabrielsteg25 Feb 2025
86% of subjects are not abnormal ! New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain Evidence our piece published today in Circulation ahajournals.org/doi/full/10.… #hypertension #prevention @EmmaVP5

New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence,...

ahajournals.org
14
32
4,164
🚨 #JobAlert Assistant spécialiste aux Explorations Fonctionnelles Rénales @hopitalbichat dès novembre 2024 👉 DFG, exploration des troubles phosphocalciques, hydro-électrolytiques... 👉 HTA (IIR et résistante, centre d'Excellence Européen) 👉 Infos et contact: DM @EmmaVP5
4
4
577
Emmanuelle Vidal-Petiot retweeted
AJKD@AJKDonline17 Jun 2024
This Core Curriculum by Susan L. Murray and Myles Wolf reviews the physiology and pathophysiology of calcium and phosphate disorders through a series of cases, including clinical conundrums commonly encountered by nephrologists: buff.ly/3Ns2PIG (FREE) @DukeKidney
70
194
17,635
Emmanuelle Vidal-Petiot retweeted
ASN Publications
@asnpublications5 Feb 2024
Hypertension is an risk factor for coronary events, stroke, heart failure, and ESKD. This study found the effects of intensive systolic BP lowering on cardiovascular end points and mortality in SPRINT were independent of time-varying diuretics use bit.ly/CJASN0406
Visual Abstract for the article titled "Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial"

ALT Visual Abstract for the article titled "Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial"

1
23
53
5,892
Emmanuelle Vidal-Petiot retweeted
JASN_News@JASN_News22 Nov 2023
Testing for 385 genes among 1623 CKD patients identified variants in 20.8%, half of whom had new or changed diagnosis, 90.7% change in management, and 32.9% change in treatment bit.ly/JASN0249 @ndahl48 @HilaMilo @fouadchebib @MayoClinicNeph @ColumbiaKidney
Visual Abstract for the article titled "The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease"

ALT Visual Abstract for the article titled "The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease"

13
3
26
5,634
Emmanuelle Vidal-Petiot retweeted
Wanpen Vongpatanasin@DrWanpen13 Nov 2023
SPRINT trial is now validated by ESPRIT RCT from China in high risk HTN including DM pts. Lowering SBP <120 compared with <140 reduces MACE by 12% , CVD death by 39%, all cause death by 21% #AHA23 🎉
2
14
38
4,805
Dietary potassium stimulates Ppp1Ca-Ppp1r1a dephosphorylation of kidney NaCl cotransporter and reduces blood pressure: buff.ly/40nDkxi @PAWellingMD @HopkinsMedicine #Nephrology
1
17
2
45
12,642
Emmanuelle Vidal-Petiot retweeted
Hypertension@HyperAHA28 Sep 2023
Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary Aldosteronism @DrJunYang @AmarLaurence @WuCent ahajrnls.org/3EYPqmV
1
6
1
12
2,206
Emmanuelle Vidal-Petiot retweeted
Matt Bailey@edinburgh_renal20 Sep 2023
New review🫶🙌 with @EdinburghBean Salt Sensitivity: Causes, Consequences, and Recent Advances | Hypertension ahajournals.org/doi/abs/10.1…

Salt Sensitivity: Causes, Consequences, and Recent Advances | Hypertension

Salt (sodium chloride) is an essential nutrient required to maintain physiological functions. However, for most people, daily salt intake far exceeds their physiological need and is habitually...

ahajournals.org
6
1
30
4,032
Emmanuelle Vidal-Petiot retweeted
Stanley Chen Cardenas@schencardenas17 Sep 2023
New somatic mutation in Primary Aldosteronism. Zinc transporter 1 (ZnT1) gene SLC30A1. Congratulations @adina_turcu and group. nature.com/articles/s41588-0…
5
1
21
2,339
Emmanuelle Vidal-Petiot retweeted
Emanuele Monda@MondaEmanuele12 Sep 2023
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality @NEJM nejm.org/doi/10.1056/NEJMoa2…
1
22
1
55
6,122
Emmanuelle Vidal-Petiot retweeted
Gerardo Gamba
@gerardo_gamba11 Sep 2023
Happy to share this review just published in @ajprenal that covers the history of NCC and the development of knowledge along the years. doi.org/10.1152/ajprenal.001…
3
12
2
59
6,575
Emmanuelle Vidal-Petiot retweeted
JAMA
@JAMA_current10 Sep 2023
Editorial: A New Dawn for Aldosterone as a Therapeutic Target in Hypertension ja.ma/3Pe3LQS #Hypertension23
7
1
19
7,577
Emmanuelle Vidal-Petiot retweeted
Wanpen Vongpatanasin@DrWanpen6 Sep 2023
Happy to share that our paper led by talented IM chief resident @KyleOMalleyMD "Diagnostic performance of the adrenal vein to IVC aldosterone ratio in classifying the subtype of PA" is published in Hypertension Research. @UTSWIMchief @Kazuomi_Kario great journal IF >5 and no OA
2
9
30
2,348
Attending the excellent Aldosterone session at #Hypertension23? Check out this State-Of-the-Art review from @AnandVaidya17 and colleagues academic.oup.com/ajh/article…
17
1
33
5,861
Emmanuelle Vidal-Petiot retweeted
Pierre Delanaye@PStoneOftheYear1 Sep 2023
New and old GFR equations: a European perspective academic.oup.com/ckj/article… A little story of estimating GFR...free access

New and old GFR equations: a European perspective

ABSTRACT. Glomerular filtration rate (GFR) is estimated in clinical practice from equations based on the serum concentration of endogenous biomarkers and d

academic.oup.com
5
1
21
1,374
Emmanuelle Vidal-Petiot retweeted
Frontiers - Physiology@FrontPhysiol31 Aug 2023
New Research: Renal K+ retention in physiological circumstances: focus on adaptation of the distal nephron and cross-talk with Na+ transport systems #Physiology frontiersin.org/articles/10.…
2
1
6
2,186
Emmanuelle Vidal-Petiot retweeted
Rein Et Tubulopathies@et_rein30 Aug 2023
Very interesting review in Pharmacology and Therapeutics by Kettritz and Loffing: "Potassium homeostasis–Physiology and Pharmacology in a clinical context." doi.org/10.1016/j.pharmthera…
4
15
798
Emmanuelle Vidal-Petiot retweeted
Sébastien Rubin@SebastienRubin25 Aug 2023
Des posts qui vous réconcilient avec Twitter/X
Thomas Clavier@ThomasClavierMD25 Aug 2023
[🔴 Thread pro de santé + grand public 🔴] Débat récurent: le casque est-il utile ou non à vélo ? 🚴‍♂️🪖 A thread ⬇️🧵 (merci de like ❤️+ RT 🔁si le thread vous semble utile / intéressant) #velo #velos #velotaff #velotaf #cyclisme #casque
1
3
738
Emmanuelle Vidal-Petiot retweeted
Thomas Stehlé@TStehl19 Aug 2023
And in this issue, our proof of concept for a personalized eGFR method, based on creatinine and muscle mass assessed by CT scan. More precise than the usual equations in case of sarcopenia or high muscle mass, and efficient regardless of ethnicity. academic.oup.com/ckj/article…

Development and validation of a new equation based on plasma creatinine and muscle mass assessed by...

ABSTRACTBackground. Inter-individual variations of non-glomerular filtration rate (GFR) determinants of serum creatinine, such as muscle mass, account for

academic.oup.com
CKJ@CKJsocial8 Aug 2023
📢Check out the new August issue of CKJ! Fully #openaccess: 📖academic.oup.com/ckj/issue/1… 🧐Editor's pick: Sodium bicarbonate in kidney transplant recipients: do some apples a day keep the doctor away? 👉doi.org/10.1093/ckj/sfad117
1
7
18
2,517
Load more